Lv1
26 积分 2024-08-14 加入
MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?
5个月前
已关闭
Atrasentan in Patients with IgA Nephropathy
5个月前
已完结
MBL2 deficiency and IgA Nephropathy in transplant patients: Is complement inhibition always beneficial?
5个月前
已关闭
The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis
5个月前
已完结
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis
5个月前
已完结
Mucin O-glycosylation and B-cell homing: a new bridge for the gut-kidney axis in IgA nephropathy?
5个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
5个月前
已完结
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
5个月前
已完结
Pathogenesis and clinical features of psoriasis
5个月前
已完结
Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation
5个月前
已完结
皖公网安备34019202002308
